Ciedon Inc.

Middletown, CT

UEI
DK5EUDM8X776
CAGE
9E7Q7
Primary NAICS
541714 Research and Development in Biotechnology (except Nanobiotechnology)
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • For Profit Organization
Entity structure
Corporate Entity (Not Tax Exempt)
SAM.gov registration date
Physical address
15 Smith St, Middletown, CT 06457, USA

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

SBA capabilities narrative

Non-small cell lung cancer (NSCLC) is the third most common cancer in the US, yet current standard-of-care is insufficient because the five-year survival rate is still around 20%. Abnormal calcium regulation has previously been suggested as an important driver for malignancy. Therefore, inhibition of calcium entry is a novel target for cancer treatment, yet no potential drugs have been produced or under development. Ciedon has produced antagonistic antibodies that specifically inhibit calcium entry into NSCLCs. Our goal will be to validate our antibodies for specificity towards NSCLCs vs. healthy cells and initial testing for their capacity to kill NSCLC tumor cells.

Quick answers

Is Ciedon Inc. registered in SAM.gov?

Yes. Ciedon Inc.'s SAM.gov registration is active through April 17, 2027.

On GovTribe

See Ciedon Inc.'s full federal record

  • Similar vendors